Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis

Yi Ping Yang, Yuh Lih Chang, Pin I. Huang, Guang Yuh Chiou, Ling Ming Tseng, Shih Hwa Chiou, Ming Hsiung Chen, Ming Teh Chen, Yang Hsin Shih, Chin Hong Chang, Chuan Chih Hsu, Hsin I. Ma, Chin Tien Wang, Lo-Lin Tsai, Cheng Chia Yu, Charn Jung Chang

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor. Patients diagnosed with GBM have a poor prognosis, and it has been reported that tumor malignancy and GBM recurrence are promoted by STAT3 signaling. As resveratrol (RV), a polyphenol in grapes, is reported to be a potent and non-toxic cancer-preventive compound, the aim of this study was to investigate the therapeutic effect and molecular mechanisms of RV on GBM-derived radioresistant tumor initiating cells (TIC). Firstly, our results showed that primary GBM-CD133 + TIC presented high tumorigenic and radiochemoresistant properties as well as increased protein levels of phosphorylated STAT3. We consistently observed that treatment with shRNA-STAT3 (sh-STAT3) or AG490, a STAT3 inhibitor, significantly inhibited the cancer stem-like cell properties and radioresistance of GBM-CD133 + in vitro and in vivo. Furthermore, treatment of GBM-CD133 + with 100μM RV induced apoptosis and enhanced radiosensitivity by suppressing STAT3 signaling. Microarray results suggested that RV or AG490 inhibited the stemness gene signatures of GBM-CD133 + and facilitated the differentiation of GBM-CD133 + into GBM-CD133 - or astrocytoma cells. Finally, xenotransplant experiments indicated that RV or sh-STAT3 therapy could significantly improve the survival rate and synergistically enhance the radiosensitivity of radiation-treated GBM-TIC. In summary, RV can reduce in vivo tumorigenicity and enhance the sensitivity of GBM-TIC to radiotherapies through the STAT3 pathway.

Original languageEnglish
Pages (from-to)976-993
Number of pages18
JournalJournal of Cellular Physiology
Volume227
Issue number3
DOIs
Publication statusPublished - Mar 2012
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Yang, Y. P., Chang, Y. L., Huang, P. I., Chiou, G. Y., Tseng, L. M., Chiou, S. H., Chen, M. H., Chen, M. T., Shih, Y. H., Chang, C. H., Hsu, C. C., Ma, H. I., Wang, C. T., Tsai, L-L., Yu, C. C., & Chang, C. J. (2012). Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. Journal of Cellular Physiology, 227(3), 976-993. https://doi.org/10.1002/jcp.22806